Strategies for Studying Mouse and Human Immune Responses to Human Papillomavirus Type 16

This publication has 30 references indexed in Scilit:

• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• Virus infections in mice with targeted gene disruptions
  Current Opinion in Immunology, 1993
• Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer
  Human Immunology, 1993
• Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes
  European Journal of Immunology, 1993
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
  Nature, 1993
• Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7
  European Journal Of Cancer, 1992
• Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
  Nature, 1991
• Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
  Nature, 1990
• Presentation of viral antigen controlled by a gene in the major histocompatibility complex
  Nature, 1990
• Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
  The Journal of Experimental Medicine, 1985